TikTok Asks Judge to Extend the Deadline for Its Sale
Francesca Billington is a dot.LA editorial intern. She's previously reported for KCRW, the Santa Monica Daily Press and local publications in New Jersey. Before joining dot.LA, she was a communications fellow at an environmental science research center in Sri Lanka. She graduated from Princeton in 2019 with a degree in anthropology.
The Trump administration's deadline for ByteDance to close a deal in the U.S. is around the corner and TikTok says it hasn't gotten an update in weeks.
The Committee on Foreign Investment in the United States (CFIUS) had set November 12 as the last date to close a business deal, but it didn't specify what would happen if things fell through.
That's what led TikTok to file a petition in the Court of Appeals for the D.C. Circuit on Tuesday. They're calling for a review of CFIUS and a 30-day extension on the deadline.
"With the November 12 CFIUS deadline imminent and without an extension in hand, we have no choice but to file a petition in court to defend our rights and those of our more than 1,500 employees in the US," TikTok told the Associated Press in a written statement.
In September, Beijing-based ByteDance announced it would sell part of its business to Walmart and Oracle, a plan Trump approved. His administration calls TikTok a national security threat, accusing the video platform of sharing user data with the Chinese Communist government, which the company denies.
The move could buy the Chinese company time as Trump is set to leave office early next year. An advisor to president-elect Joe Biden told CNBC it was "too early to say" Biden's thoughts on the social media app.
Meanwhile, TikTok's former CEO Kevin Mayer, who left amid sustained pressure from the Trump administration, has joined Len Blavatnik's investment firm Access Industries as a senior advisor.
His role will place him at the center of media and entertainment deals — Access has stakes in giants like Warner Music Group, audio streaming service Deezer and DAZN, a sports streaming service. Mayer, a former Disney executive, left TikTok after just under three months on the job.
"I look forward to helping Access build on the success of its leading media and entertainment businesses as a key component of my future endeavors," Mayer said in a statement announcing the news.
- TikTok Employee Patrick Ryan Sues Trump for Defamation - dot.LA ›
- TikTok a 'Direct Threat' to US Security, Justice Dept. Says - dot.LA ›
- Could U.S. Ban Chinese-Owned TikTok? - dot.LA ›
- DOJ: TikTok Employees Will Get Paid Despite Trump's Order - dot.LA ›
- TikTok, WeChat Ban from U.S. App Stores Set for Sunday ›
- TikTok Sale Deadline Extended - dot.LA ›
Subscribe to our newsletter to catch every headline.
The spread of the novel coronavirus has sped the adoption of telemedicine in the United States, eliminating barriers like insurance reimbursements. It's also shone a light on the need for faster vaccines and a need for greater investment in public health, experts said on a dot.LA virtual panel Tuesday that looked at how investors are responding to COVID-19.
A move to telemedicine "was a long time coming," said Dr. Jeffrey Klausner, a professor of medicine in the division of infectious diseases in the David Geffen School of Medicine at UCLA. "A lot of doctors and institutions weren't comfortable with that" but now those concerns have been "blown out of the water." Since the pandemic erupted, two-thirds of UCLA medical visits have been done using telehealth.
Dr. Jeffrey Klausner, MD, MPH, is a Professor of Medicine in the Division of Infectious Diseases in the David Geffen School of Medicine.
Jeffrey Klausner, MD, MPH, is a Professor of Medicine in the Division of Infectious Diseases in the David Geffen School of Medicine and Adjunct Professor of Epidemiology in the Fielding School of Public Health.<p>Dr. Klausner earned his Medical Degree from Cornell University Medical College with Honors in Research. He completed his Residency in Internal Medicine at the New York University—Bellevue Hospital Center. Dr. Klausner earned his Master's in Public Health with a focus on International Health and Epidemiology at the Harvard School of Public Health. After that training, Dr. Klausner was an Epidemic Intelligence Service Officer at the Centers for Disease Prevention and Control. Dr. Klausner completed his Fellowship in Infectious Diseases at the University of Washington, Seattle.</p>
Jay Goss is General Partner at Wavemaker Three-Sixty Health
Jay Goss, General Partner @ Wavemaker Three-Sixty Health<p><span id="selection-marker-1" class="redactor-selection-marker" data-verified="redactor"></span>Jay is a General Partner at Wavemaker Three-Sixty Health. Wavemaker Three-Sixty Health is Southern California's leading Seed-stage healthcare-focused venture capital fund. The fund's investment thesis is that after 40+ years, healthcare is transitioning away from fee-for-service to value-based payments, and with that comes a massive amount of disruption. There will be no shortage of clinical operations and business challenges to solve in the coming decade, and entrepreneurs are already coming out of the woodwork to solve these problems. Moreover, countless business models are now for the first time commercially viable because the healthcare industry is embracing value-based payments. The fund counts among its investors 50+ healthcare senior executives, eager and extremely able to add value to the early stage companies in which the fund invests. Prior to launching Wavemaker Three-Sixty Health, Jay operated dozens of early stage companies all over Southern California, and advised dozens more.<span id="selection-marker-2" class="redactor-selection-marker" data-verified="redactor"></span> </p>
Llewellyn Cox is a general partner at MarsBio
Llewellyn Cox, General Partner at MarsBio<p>Llewellyn is an entrepreneur from Gillingham, Kent, England. He founded LabLaunch, the leading biotechnology incubator network in Southern California, and BioBuilt, a firm that assists early-stage companies in building lab space.Llewellyn received a Ph.D. in Molecular and Cell Biology at Cardiff University, before moving to New York City to perform postdoc research in neuroscience at Weill Cornell Medical College. Llewellyn is an adjunct professor at Keck Medicine of USC where he teaches translational biology and science communications.</p>
Rachel Uranga, is a reporter at dot.LA.
Rachel Uranga, Reporter @dot.LA<p>Rachel covers the intersection of business, technology and culture. She is a former Mexico-based market correspondent at Reuters and has worked for several Southern California news outlets, including the Los Angeles Business Journal and the Los Angeles Daily News. She has covered everything from IPOs to immigration. Uranga is a graduate of the Columbia School of Journalism and California State University Northridge. A Los Angeles native, she lives with her husband, son and their felines. </p>
- Investors Are Still Writing Checks During the Coronavirus Pandemic ... ›
- venture-capital - dot.LA ›
- Here Are the Investors Still Writing Checks During the Coronavirus ... ›
- Leading VC Warns Coronavirus is a 'Black Swan' Event - dot.LA ›
- Coronavirus Stokes Investor Fears – From Venture Capital to Wall ... ›
- L.A. Venture Capital Firm MarsBio Scrambles to Secure Cash ... ›
- Coronavirus Updates: Virgin Orbit Gets OK on Ventilators, Curative Signs Pact With Air Force - dot.LA ›
- Watch Three Los Angeles Health Startups Pitch Investors - dot.LA ›
- Can LA County's New Fund Get Local Biotech Startups to Stick Around? - dot.LA ›
- Heal Get's $100M in Humana Deal to Extend Telehealth - dot.LA ›
- Making At-Home Healthcare As Easy as Ordering Pizza - dot.LA ›
- The LA Dodgers Get Into Food Delivery - dot.LA ›
Here's the deal: the first segment of a three-part Joe Biden interview aired Wednesday on Snapchat's "Good Luck America." Parts two and three will follow on Thursday and Friday, respectively.
Interviewer Peter Hamby did not mince words in asking Biden about his being perceived as "old, out of touch, and kind of lame."
- joe-biden - dot.LA ›
- Joe Biden Takes to Snapchat's 'Good Luck America.' - dot.LA ›
- Snap Removes Trump's Account From its Discover Platform - dot.LA ›
- An AI Debate Analysis Shows Trump in Character - dot.LA ›